0
0.5
1
1.5
2+
Mortality
87%
Improvement
Relative Risk
Ventilation
77%
Respiratory failure
88%
Probiotics d'Ettorre et al. LATE TREATMENT
Is late treatment with probiotics beneficial for COVID-19?
Retrospective 70 patients in Italy
Lower progression with probiotics (p=0.011)
c19early.org
d'Ettorre et al., Frontiers in Medicine, Jul 2020
Favors probiotics
Favors control